Feeds
13341 items (13341 unread) in 74 feeds
Acinar Cell Carcinoma
(176 unread)
Acinic Cell Carcinoma
(71 unread)
Adenoid Cystic Carcinoma
(267 unread)
Adrenal Gland Cancer
(1113 unread)
Ampulla Of Vater
(127 unread)
Anal Cancer
(1015 unread)
Angiosarcoma
(353 unread)
Appendix Cancer
(226 unread)
Bile Duct Cancer
(1865 unread)
Brain and CNS
(1828 unread)
Carcinoid
(479 unread)
Endocrine/Neuroendocrine
(1349 unread)
Gall Bladder Cancer
(627 unread)
Hemangioendothelioma
(301 unread)
Hepatoblastoma
(194 unread)
Pancreas
(254 unread)
Phyllodes
(152 unread)
PMP and Mucinous Tumors
(144 unread)
Rhabdomyosarcoma
(606 unread)
Sarcoma
(2194 unread)
Google - Angiosarcoma (100 unread)
-
TRACON Pharmaceuticals Inc (NASDAQ:TCON) Short Interest Update - Slater Sentinel
Posted: January 18th, 2020, 9:13am GMT
TRACON Pharmaceuticals Inc (NASDAQ:TCON) Short Interest Update Slater Sentinel -
HC Wainwright Reiterates “Buy” Rating for TRACON Pharmaceuticals (NASDAQ:TCON) - Slater Sentinel
Posted: January 17th, 2020, 10:42am GMT
-
HC Wainwright Raises TRACON Pharmaceuticals (NASDAQ:TCON) Price Target to $18.00 - Riverton Roll
Posted: January 16th, 2020, 9:24pm GMT
-
Angiosarcomas Treatment Market 2019 Trends, Growth Opportunities, Key Players Analysis and Forecast to 2026 – Dagoretti News - Dagoretti News
Posted: January 16th, 2020, 7:54am GMT
-
Breast cancer symptoms: Early signs, pictures, and more - Medical News Today
Posted: January 15th, 2020, 1:07am GMT
Breast cancer symptoms: Early signs, pictures, and more Medical News Today -
TRACON Pharmaceuticals (NASDAQ:TCON) PT Raised to $18.00 - Slater Sentinel
Posted: January 15th, 2020, 10:37pm GMT
TRACON Pharmaceuticals (NASDAQ:TCON) PT Raised to $18.00 Slater Sentinel -
TRACON Pharmaceuticals Inc (NASDAQ:TCON) Sees Large Growth in Short Interest - Riverton Roll
Posted: January 13th, 2020, 9:11am GMT
-
Angiosarcomas Treatment Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2024 - Pro News Time
Posted: January 12th, 2020, 7:52am GMT
-
Living with cancer and hope - Sandton Chronicle
Posted: January 12th, 2020, 2:15am GMT
Living with cancer and hope Sandton Chronicle -
TRACON Pharmaceuticals (NASDAQ:TCON) Stock Price Up 5.1% - Riverton Roll
Posted: January 11th, 2020, 2:53pm GMT
TRACON Pharmaceuticals (NASDAQ:TCON) Stock Price Up 5.1% Riverton Roll -
TRACON Pharmaceuticals Inc (NASDAQ:TCON) Short Interest Up 218.6% in December - Slater Sentinel
Posted: January 11th, 2020, 9:11am GMT
-
What will be the biggest scientific breakthrough of 2020? - Stuff.co.nz
Posted: January 10th, 2020, 2:00pm GMT
-
Poison to Body and Soul - Sojourners
Posted: January 9th, 2020, 5:58pm GMT
Plastic and the State of Our Souls Sojourners -
Community Briefs: Jan. 9 - The Herald Bulletin
Posted: January 9th, 2020, 12:00pm GMT
Community Briefs: Jan. 9 The Herald Bulletin -
HC Wainwright Boosts TRACON Pharmaceuticals (NASDAQ:TCON) Price Target to $18.00 - Riverton Roll
Posted: January 9th, 2020, 3:21am GMT
-
Comparing Champions Oncology (NASDAQ:CSBR) & TRACON Pharmaceuticals (NASDAQ:TCON) - Slater Sentinel
Posted: January 8th, 2020, 3:37am GMT
-
Angiosarcomas Treatment Market Size with Statistics Data, Revenue Status and Future Industry Trends by 2026 - Primo Journal
Posted: January 7th, 2020, 10:52am GMT
-
HC Wainwright Boosts TRACON Pharmaceuticals (NASDAQ:TCON) Price Target to $18.00 - Slater Sentinel
Posted: January 7th, 2020, 4:40am GMT
-
TRACON Pharmaceuticals Inc (NASDAQ:TCON) Sees Large Drop in Short Interest - Riverton Roll
Posted: January 5th, 2020, 1:39am GMT
-
TRACON Pharmaceuticals (NASDAQ:TCON) Sees Strong Trading Volume - Slater Sentinel
Posted: January 4th, 2020, 2:21pm GMT
TRACON Pharmaceuticals (NASDAQ:TCON) Sees Strong Trading Volume Slater Sentinel -
Brokerages Anticipate TRACON Pharmaceuticals Inc (NASDAQ:TCON) Will Announce Earnings of -$1.58 Per Share - Riverton Roll
Posted: January 2nd, 2020, 12:48pm GMT
-
Athenex: Compelling Overall Survival Advantage For Oral Paclitaxel, Revaluation In Progress - Seeking Alpha
Posted: December 31st, 2019, 5:16pm GMT
-
Brokerages Anticipate TRACON Pharmaceuticals Inc (NASDAQ:TCON) Will Announce Earnings of -$1.58 Per Share - Trent Times
Posted: December 30th, 2019, 11:46am GMT
-
TRACON Pharmaceuticals (NASDAQ:TCON) Price Target Increased to $18.00 by Analysts at HC Wainwright - Slater Sentinel
Posted: December 30th, 2019, 10:42am GMT
-
TRACON Pharmaceuticals (NASDAQ:TCON) Upgraded to Buy by ValuEngine - Slater Sentinel
Posted: December 29th, 2019, 8:19am GMT
-
Upcycling used uniforms for cancer-stricken firefighters - 코리아타임스
Posted: December 29th, 2019, 5:20am GMT
-
Upcycling used uniforms for cancer-stricken firefighters - Korea Times
Posted: December 29th, 2019, 5:20am GMT
-
Upcycling used uniforms for cancer-stricken firefighters - Korea Times
Posted: December 29th, 2019, 5:20am GMT
-
TRACON Pharmaceuticals Inc (NASDAQ:TCON) Short Interest Update - Slater Sentinel
Posted: December 27th, 2019, 7:07am GMT
TRACON Pharmaceuticals Inc (NASDAQ:TCON) Short Interest Update Slater Sentinel -
TRACON Pharmaceuticals Inc (NASDAQ:TCON) Short Interest Update - Trent Times
Posted: December 26th, 2019, 4:52pm GMT
-
Angiosarcomas Treatment Market to Register a Stout Growth by End 2024 - Market Reports Observer
Posted: December 26th, 2019, 7:01am GMT
Angiosarcomas Treatment Market to Register a Stout Growth by End 2024 Market Reports Observer -
TRACON Pharmaceuticals (NASDAQ:TCON) and Champions Oncology (NASDAQ:CSBR) Head to Head Review - Slater Sentinel
Posted: December 24th, 2019, 9:27am GMT
-
Orphan Drugs Market and Competitive Landscape Report 2019 - Market Reports Observer
Posted: December 23rd, 2019, 12:53pm GMT
Orphan Drugs Market and Competitive Landscape Report 2019 Market Reports Observer -
A Global Digital Media Network - Digital Journal
Posted: December 23rd, 2019, 7:42am GMT
A Global Digital Media Network Digital Journal -
Heart Tumor Market 2019 Global Recent Trends, Competitive Landscape, Size, Segments, Emerging Technologies and Industry Growth by Forecast to 2023 - Press Release - Digital Journal
Posted: December 23rd, 2019, 7:42am GMT
-
Analysts Anticipate TRACON Pharmaceuticals Inc (NASDAQ:TCON) Will Announce Earnings of -$1.57 Per Share - Slater Sentinel
Posted: December 22nd, 2019, 2:35pm GMT
-
Head to Head Survey: TRACON Pharmaceuticals (NASDAQ:TCON) & Champions Oncology (NASDAQ:CSBR) - Riverton Roll
Posted: December 22nd, 2019, 9:02am GMT
-
TRACON Pharmaceuticals (NASDAQ:TCON) Stock Rating Upgraded by ValuEngine - Slater Sentinel
Posted: December 21st, 2019, 2:20pm GMT
-
TRACON Pharmaceuticals, 3D Medicines and Jiangsu Alphamab Announce Partnership for Development of Subcutaneous PD-L1 Single-Domain Antibody in Soft Tissue Sarcoma - BioSpace
Posted: December 20th, 2019, 12:01pm GMT
-
Short Interest in TRACON Pharmaceuticals Inc (NASDAQ:TCON) Drops By 65.7% - Slater Sentinel
Posted: December 19th, 2019, 1:03pm GMT
-
TRACON Pharmaceuticals (NASDAQ:TCON) Upgraded to “Buy” at ValuEngine - Riverton Roll
Posted: December 18th, 2019, 3:11am GMT
-
BELLUS Health Inc. (BLU) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) Comparison side by side - The Broch Herald
Posted: December 17th, 2019, 6:38pm GMT
-
Ray Hayhurst, senior vice president of Avison Young’s Orlando office, dies at 73 - GrowthSpotter
Posted: December 17th, 2019, 3:40pm GMT
-
Comparing of ESSA Pharma Inc. (EPIX) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) - The Broch Herald
Posted: December 17th, 2019, 11:28am GMT
-
BioXcel Therapeutics Inc. (BTAI)'s Financial Results Comparing With TRACON Pharmaceuticals Inc. (NASDAQ:TCON) - The Broch Herald
Posted: December 15th, 2019, 1:28pm GMT
-
Concert Pharmaceuticals Inc. (CNCE)'s Financial Results Comparing With TRACON Pharmaceuticals Inc. (NASDAQ:TCON) - The Broch Herald
Posted: December 15th, 2019, 1:12pm GMT
-
Zacks: Analysts Anticipate TRACON Pharmaceuticals Inc (NASDAQ:TCON) Will Post Earnings of -$1.57 Per Share - NCTY News
Posted: December 15th, 2019, 11:30pm GMT
-
Contrasting of Stealth BioTherapeutics Corp (MITO) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) - The CoinGlobalist
Posted: December 14th, 2019, 11:47am GMT
-
Equillium Inc. (EQ)'s Financial Results Comparing With TRACON Pharmaceuticals Inc. (NASDAQ:TCON) - The Broch Herald
Posted: December 14th, 2019, 11:36am GMT
-
Reviewing TRACON Pharmaceuticals Inc. (TCON)'s and SIGA Technologies Inc. (NASDAQ:SIGA)'s results - The Broch Herald
Posted: December 14th, 2019, 3:55am GMT
-
Reviewing TRACON Pharmaceuticals Inc. (TCON)'s and Bicycle Therapeutics plc (NASDAQ:BCYC)'s results - The Broch Herald
Posted: December 14th, 2019, 10:15pm GMT
-
TRACON Pharmaceuticals (NASDAQ:TCON) Upgraded by ValuEngine to “Buy” - Slater Sentinel
Posted: December 13th, 2019, 8:20pm GMT
-
Tracon Pharmaceuticals Inc (NASDAQ:TCON) on Focus After Report of Less Shorts - The Lamp News
Posted: December 13th, 2019, 6:49pm GMT
-
TRACON Pharmaceuticals Inc. (TCON) and Surface Oncology Inc. (NASDAQ:SURF) Contrasting side by side - The CoinGlobalist
Posted: December 13th, 2019, 3:46am GMT
-
Zacks: Analysts Expect TRACON Pharmaceuticals Inc (NASDAQ:TCON) to Announce -$1.57 EPS - TechNewsObserver
Posted: December 12th, 2019, 8:03pm GMT
-
TRACON Pharmaceuticals Inc (NASDAQ:TCON) Sees Large Drop in Short Interest - Slater Sentinel
Posted: December 12th, 2019, 12:59pm GMT
-
TRACON Pharmaceuticals Inc (NASDAQ:TCON) Short Interest Update - Trent Times
Posted: December 12th, 2019, 10:49pm GMT
-
Reviewing Achieve Life Sciences Inc. (ACHV)'s and TRACON Pharmaceuticals Inc. (NASDAQ:TCON)'s results - The Broch Herald
Posted: December 11th, 2019, 4:21am GMT
-
Alzheimer's Drugs Market Growing by Increasing Market Share and Forecast 2026 - Gazette Quest
Posted: December 10th, 2019, 4:10pm GMT
-
TRACON Pharmaceuticals Inc (NASDAQ:TCON) Expected to Post Earnings of -$1.57 Per Share - Riverton Roll
Posted: December 10th, 2019, 1:55pm GMT
-
TRACON Pharmaceuticals (NASDAQ:TCON) Upgraded by ValuEngine to “Buy” - Riverton Roll
Posted: December 10th, 2019, 9:35am GMT
-
Comparison of TRACON Pharmaceuticals Inc. (TCON) and Merus N.V. (NASDAQ:MRUS) - The Broch Herald
Posted: December 10th, 2019, 3:41am GMT
-
Publication of First In-Human Data Reveals Safety & Efficacy of Tigilanol Tiglate in Solid Tumours - BioSpace
Posted: December 9th, 2019, 5:37pm GMT
-
Angiosarcomas Treatment Market to Register a Stout Growth by End 2024 - Techi Labs
Posted: December 9th, 2019, 6:39am GMT
-
Angiosarcomas Treatment Market to Register a Stout Growth by End 2024 - Techi Labs
Posted: December 9th, 2019, 6:37am GMT
-
Soft Tissue Sarcoma Treatment Market Development, Key Opportunity and Analysis of Leading Players to 2017 – 2025 - Wolf Mirror
Posted: December 9th, 2019, 3:27am GMT
-
Can-Fite BioPharma Ltd. (CANF)'s Financial Results Comparing With TRACON Pharmaceuticals Inc. (NASDAQ:TCON) – Coin Globalist - The CoinGlobalist
Posted: December 8th, 2019, 12:31am GMT
-
TRACON Pharmaceuticals Inc. (TCON)'s Financial Results Comparing With Ophthotech Corporation (:) – Coin Globalist - The CoinGlobalist
Posted: December 7th, 2019, 8:14pm GMT
-
ValuEngine Upgrades TRACON Pharmaceuticals (NASDAQ:TCON) to “Buy” - Mitchell Messenger
Posted: December 7th, 2019, 4:12pm GMT
ValuEngine Upgrades TRACON Pharmaceuticals (NASDAQ:TCON) to “Buy” Mitchell Messenger -
TRACON Pharmaceuticals (NASDAQ:TCON) Upgraded by ValuEngine to Buy - NCTY News
Posted: December 7th, 2019, 4:11pm GMT
-
Angiosarcomas Treatment Market Trends, Regulations And Competitive Landscape Outlook to 2016 - 2024 - The Market Expedition
Posted: December 7th, 2019, 6:32am GMT
-
TRACON Pharmaceuticals Inc. (TCON) and Bicycle Therapeutics plc (NASDAQ:BCYC) Comparison side by side - The CoinGlobalist
Posted: December 6th, 2019, 1:49pm GMT
-
The clinical trial of Boron neutron capture therapy - Industry Global News 24
Posted: December 6th, 2019, 11:48am GMT
The clinical trial of Boron neutron capture therapy Industry Global News 24 -
Comparison of TRACON Pharmaceuticals Inc. (TCON) and MannKind Corporation (NASDAQ:MNKD) - The Broch Herald
Posted: December 5th, 2019, 8:53pm GMT
-
TRACON Pharmaceuticals Inc. (TCON) and SIGA Technologies Inc. (NASDAQ:SIGA) Comparing side by side - The Broch Herald
Posted: December 5th, 2019, 1:11am GMT
-
Reviewing TRACON Pharmaceuticals Inc. (TCON)'s and Capricor Therapeutics Inc. (NASDAQ:CAPR)'s results - The Broch Herald
Posted: December 4th, 2019, 9:11pm GMT
-
Analysts Anticipate TRACON Pharmaceuticals Inc (NASDAQ:TCON) Will Announce Earnings of -$1.57 Per Share - Mitchell Messenger
Posted: December 4th, 2019, 3:03pm GMT
-
TRACON Pharmaceuticals (NASDAQ:TCON) Rating Increased to Buy at ValuEngine - Darby News
Posted: December 4th, 2019, 9:50am GMT
-
Constellation Pharmaceuticals Inc. (CNST) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) Comparing side by side - The Broch Herald
Posted: December 4th, 2019, 2:47am GMT
-
FY2019 Earnings Forecast for TRACON Pharmaceuticals Inc (NASDAQ:TCON) Issued By Jefferies Financial Group - Mitchell Messenger
Posted: December 3rd, 2019, 9:31pm GMT
-
Reviewing Deciphera Pharmaceuticals Inc. (DCPH)'s and TRACON Pharmaceuticals Inc. (NASDAQ:TCON)'s results - The Broch Herald
Posted: December 3rd, 2019, 5:33pm GMT
-
Reviewing Sangamo Therapeutics Inc. (SGMO)'s and TRACON Pharmaceuticals Inc. (NASDAQ:TCON)'s results - The Broch Herald
Posted: December 3rd, 2019, 2:38am GMT
-
Equities Analysts Offer Predictions for TRACON Pharmaceuticals Inc’s FY2020 Earnings (NASDAQ:TCON) - Mitchell Messenger
Posted: December 3rd, 2019, 12:19am GMT
-
Genfit SA (GNFT)'s Financial Results Comparing With TRACON Pharmaceuticals Inc. (NASDAQ:TCON) - The Broch Herald
Posted: December 2nd, 2019, 1:40pm GMT
-
Reviewing G1 Therapeutics Inc. (GTHX)'s and TRACON Pharmaceuticals Inc. (NASDAQ:TCON)'s results - The Broch Herald
Posted: November 30th, 2019, 3:32am GMT
-
TRACON Pharmaceuticals (NASDAQ:TCON) Announces Quarterly Earnings Results - Trent Times
Posted: November 30th, 2019, 2:06am GMT
-
Angiosarcomas Treatment Market Expected to Witness a Sustainable Growth by 2024 - Montana Ledger
Posted: November 29th, 2019, 7:32am GMT
-
Angiosarcomas Treatment Market to Surge at a Robust Pace by 2024 - Statsflash
Posted: November 29th, 2019, 7:16am GMT
-
Tracon Pharmaceuticals Inc (NASDAQ:TCON) Shorts Decreased by 9.01% After Short Covering - The Lamp News
Posted: November 28th, 2019, 12:22pm GMT
-
FY2019 Earnings Forecast for TRACON Pharmaceuticals Inc (NASDAQ:TCON) Issued By Jefferies Financial Group - Trent Times
Posted: November 28th, 2019, 3:49am GMT
-
TRACON Pharmaceuticals’ (NASDAQ:TCON) Buy Rating Reaffirmed at HC Wainwright - Trent Times
Posted: November 26th, 2019, 4:14pm GMT
-
BlackRock Inc. Sells 46,818 Shares of TRACON Pharmaceuticals Inc (NASDAQ:TCON) - TechNewsObserver
Posted: November 25th, 2019, 9:49pm GMT
-
Jefferies Financial Group Weighs in on TRACON Pharmaceuticals Inc’s FY2020 Earnings (NASDAQ:TCON) - Mitchell Messenger
Posted: November 25th, 2019, 6:22am GMT
-
FY2020 Earnings Forecast for TRACON Pharmaceuticals Inc (NASDAQ:TCON) Issued By Jefferies Financial Group - TechNewsObserver
Posted: November 24th, 2019, 4:44am GMT
-
Angiosarcomas Treatment Market Insight on the Important Factors and Trends Influencing the Industry - Montana Ledger
Posted: November 22nd, 2019, 11:19am GMT
-
HC Wainwright Reiterates “Buy” Rating for TRACON Pharmaceuticals (NASDAQ:TCON) - TechNewsObserver
Posted: November 22nd, 2019, 5:19am GMT
-
Angiosarcomas Treatment Market Global Industry Analysis and Business Opportunity - Crypto Journal
Posted: November 21st, 2019, 10:50am GMT
-
TRACON Pharmaceuticals Inc (NASDAQ:TCON) to Post FY2019 Earnings of ($7.60) Per Share, Jefferies Financial Group Forecasts - Trent Times
Posted: November 20th, 2019, 10:39am GMT
-
Angiosarcomas Treatment Market Outlook Global Market Size, Share, Development, Growth And Demand Forecast 2026 - Downey Magazine
Posted: November 20th, 2019, 5:26am GMT
-
Analysts Anticipate TRACON Pharmaceuticals Inc (NASDAQ:TCON) Will Announce Earnings of -$1.57 Per Share - Mitchell Messenger
Posted: November 19th, 2019, 9:03pm GMT